T
Tapas R. Nayak
Researcher at University of Wisconsin-Madison
Publications - 31
Citations - 3239
Tapas R. Nayak is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Biodistribution & Molecular imaging. The author has an hindex of 18, co-authored 31 publications receiving 2845 citations. Previous affiliations of Tapas R. Nayak include National University of Singapore & Indian Institute of Technology Kharagpur.
Papers
More filters
Journal ArticleDOI
Graphene for Controlled and Accelerated Osteogenic Differentiation of Human Mesenchymal Stem Cells
Tapas R. Nayak,Henrik Andersen,Venkata S. Makam,Clement Khaw,Sukang Bae,Xiangfan Xu,Pui Lai Rachel Ee,Jong Hyun Ahn,Byung Hee Hong,Giorgia Pastorin,Giorgia Pastorin,Barbaros Özyilmaz,Barbaros Özyilmaz +12 more
TL;DR: It is shown that graphene provides a promising biocompatible scaffold that does not hamper the proliferation of human mesenchymal stem cells and accelerates their specific differentiation into bone cells, demonstrating graphene's potential for stem cell research.
Journal ArticleDOI
Biomedical Applications of Zinc Oxide Nanomaterials
TL;DR: The current status of the use of ZnO nanomaterials for biomedical applications, such as biomedical imaging, drug delivery, gene delivery, and biosensing of a wide array of molecules of interest are summarized.
Journal ArticleDOI
Graphene: a versatile nanoplatform for biomedical applications
TL;DR: Although literature reports have mixed findings, the key question is not how toxic graphene itself is, but how to modify and functionalize it and its derivatives so that they do not exhibit acute/chronic toxicity, can be cleared from the body over time, and thereby can be best used for biomedical applications.
Journal ArticleDOI
In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene.
Hao Hong,Kai Yang,Yin Zhang,Jonathan W. Engle,Liangzhu Feng,Yunan Yang,Tapas R. Nayak,Shreya Goel,Jero Bean,Charles P. Theuer,Todd E. Barnhart,Zhuang Liu,Weibo Cai +12 more
TL;DR: It is demonstrated that nanographene can be specifically directed to the tumor neovasculature in vivo through targeting of CD105 (i.e., endoglin), a vascular marker for tumor angiogenesis, and establishes CD105 as a promising vascular target for future cancer nanomedicine.
Journal ArticleDOI
In vivo targeting and positron emission tomography imaging of tumor vasculature with 66Ga-labeled nano-graphene
Hao Hong,Yin Zhang,Jonathan W. Engle,Tapas R. Nayak,Charles P. Theuer,Robert J. Nickles,Todd E. Barnhart,Weibo Cai +7 more
TL;DR: Successful demonstration of in vivo tumor targeting with GO, along with the versatile chemistry of graphene-based nanomaterials, makes them suitable nanoplatforms for future biomedical research such as cancer theranostics.